Mast Cell-Lineage Versus Basophil Lineage Involvement in Myeloproliferative and Myelodysplastic Syndromes: Diagnostic Role of Cell-Immunopheno typing

References

• Ehrlich P. Beiträge zur Kenntnis der granulierten Bindegewebszellen und der eosinophilen Leukozyten. Arch. Anat. Physiol. 1879; 3: 166–169
   Google Scholar
• Zucker-Franklin D. Ultrastructural evidence for the common origin of human mast cells and basophils. Blood 1980; 56: 534–549
   PubMed Web of Science ®Google Scholar
• Dvorak A.M. Basophil and mast cell degradation and recovery. Blood Cell Biochemistry, J.R. Harris. Plenum Press, New York 1991; 1–370
   Google Scholar
• MacGlashan D.W., Schleimer R.P., Peters S.P., Schulman E.S., Adams G.K., Sobotka A.K., Newball H.H., Lichtenstein L.M. Comparative studies of human basophils and mast cells. Fed. Proc 1983; 42: 2504–2509
   PubMedGoogle Scholar
• Valent P., Ashman L.K., Hinterberger W., Eckersberger F., Majdic O., Lechner K., Bettelheim P. Mast cell typing : demonstration of a distinct hemopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 1989; 73: 1778–1785
   PubMed Web of Science ®Google Scholar
• Agis H., Willheim M., Sperr W.R., Wilfing A., Krömer E., Kabrna E., Spanblöchl E., Strobl H., Geissler K., Spittler A., Boltz-Nitulescu G., Majdic O., Lechner K., Valent P. Monocytes do not make mast cells when cultured in the presence of SCF: Characterization of the circulating mast cell progenitor as a c-kit+ CD34+ Ly-, CD14-, CD17-, colony forming cell. J. Immunol. 1993; 151: 4221–4227
   PubMed Web of Science ®Google Scholar
• Galli S.J. Biology of disease: New insights into ‘the riddle of the mast cells’: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 1990; 62: 5–33
   PubMed Web of Science ®Google Scholar
• Schrader J.W., Lewis S.J., Clark-Lewis I., Culvenor J.G. The persisting (P) cell: histamine content, regulation by a T cell derived factor, origin from a bone marrow precursor and relationship to mast cell. Proc. Natl. Acad. Sci. (USA) 1981; 78: 323–328
   PubMed Web of Science ®Google Scholar
• Födinger M., Fritsch G., Winkler K., Emminger W., Mitterbauer G., Gadner H., Valent P., Mannhalter Ch. Origin of human mast cells: Development from transplanted hemopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994; 84: 2954–2459
   PubMed Web of Science ®Google Scholar
• Parwaresch M.R., Homy H.P., Lennert K. Tissue mast cells in health and disease. Path. Res. Pract. 1985; 179: 439–461
   PubMed Web of Science ®Google Scholar
• Galli S.J. New Concepts about the mast cell. N. Engl. J. Med. 1993; 328: 257–265
   PubMed Web of Science ®Google Scholar
• Dvorak A.M. Human mast cells. Ultrastructural observations of in situ, ex vivo, and in vitro sites, sources and systems. The Mast Cell in Health and Diseases, A.M. Kaliner, D.D. Metcalfe. Marcel Dekker Inc., New York 1993; 1–78
   Google Scholar
• Schwartz L.B., Huff T.F. Mast cells. The Lung, R.G. Crystal, J.B. West. Raven Press, New York, NY 1991; 601–16
   Google Scholar
• Soler J., O'Brian M., DeCastro J.T., Miguel J. F. S., Kearney L., Goldman J.M., Catovsky D. Blast crisis of chronic granulocytic leukemia with mast cell and basophilic precursors. Am. J. Clin. Pathol. 1985; 83: 254–259
   PubMed Web of Science ®Google Scholar
• Parkin J.L., McKenna R.W., Brunning R.D. Ultrastructural features of basophil and mast cell granulopoiesis in blastic phase Philadelphia chromosome-positive leukemia. J. Natl. Cane. Inst. 1980; 65: 535–539
   PubMed Web of Science ®Google Scholar
• Lennert K., Parwaresch M.R. Mast cells and mast cell neoplasia: a review. Histopathology 1979; 3: 349–365
   PubMed Web of Science ®Google Scholar
• Juhlin L. Basophil and eosinophil leukocytes in various internal disorders. Acta. Med Scand. 1963; 174: 249–255
   PubMed Web of Science ®Google Scholar
• Denburg J.A., Wilson W. E. C., Bienenstock J. Basophil production in myeloproliferative disorders: increases during blastic transformation of chronic myeloid leukemia. Blood 1982; 60: 113–120
   PubMed Web of Science ®Google Scholar
• Prokocimer M., Polliack A. Increased bone marrow mast cells in preleukemic syndromes, acute myeloid leukemias and lympho-proliferative disorders. Am. J. Clin. Pathol 1980; 75: 34–38
   Web of Science ®Google Scholar
• Arnalich F., Lahoz C., Larrocha C., Zamorano A.F., Jimenez G., Gasalla R., Garcia-Puig J., Vazquez J.J. Incidence and clinical significance of peripheral and bone marrow basophilia. J. Medicine 1987; 18: 293–299
   Web of Science ®Google Scholar
• Valent P., Bettelheim P. Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Adv. Immunol. 1992; 52: 333–421
   PubMed Web of Science ®Google Scholar
• Kitamura Y., Yokoyama M., Matsuda H., Ohno T., Mori K.J. Spleen colony forming cell as common precursor for tissue mast cells and granulocytes. Nature 1981; 291: 159–160
   PubMed Web of Science ®Google Scholar
• Kirshenbaum A.S., Goff J.P., Kessler S.W., Mican J.M., Zsebo K.M., Metcalfe D.D. Effects of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34+ pluripotent progenitor cells. J. Immunol 1992; 148: 772–777
   PubMed Web of Science ®Google Scholar
• Kirschenbaum A.S., Kessler S.W., Goff J.P., Metcalfe D.D. Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol. 1991; 146: 1410–1415
   PubMed Web of Science ®Google Scholar
• Rottem M., Okada T., Goff J.P., Metcalfe D.D. Mast cells cultured from peripheral blood of normal donors and patients with mastocytosis originate from a CD34+/FcϵRI– cell population. Blood 1994; 84: 2489–2496
   PubMed Web of Science ®Google Scholar
• Abboud M., Moore M. A. S. Recombinant human IL-3 is a basophil/mast cell growth factor. Exp. Hematol. 1988; 16: 489, (abst)
   Web of Science ®Google Scholar
• Valent P., Sillaber C., Bettelheim P. The growth and differentiation of mast cells. Prog. Growth Factor Res. 1991; 3: 27–41
   PubMedGoogle Scholar
• Valent P. The riddle of the mast cell: kit ligand as the missing link?. Immunology Today 1994; 15: 111–114
   PubMedGoogle Scholar
• Valent P., Schmidt G., Besemer J., Mayer P., Zenke G., Liehl E., Hinterberger W., Lechner K., Bettelheim P. Interleukin-3 is a differentiation factor for human basophils. Blood 1989; 73: 1763–1769
   PubMed Web of Science ®Google Scholar
• Hirai K., Morita Y.M., Misaki Y., Ohta K., Takaishi T., Suzuki S., Motoyoshi K., Miyamoto T. Modulation of human basophil histamine release by hemopoietic growth factors. J. Immunol. 1988; 141: 3958–3964
   PubMed Web of Science ®Google Scholar
• Schleimer R.P., Derse C.P., Friedmann B., Gillis S., Plaut M., Lichtenstein L.M., MacGlashan D.W. Regulation of basophil mediator release by cytokines. J. Immunol. 1989; 143: 1310–1317
   PubMed Web of Science ®Google Scholar
• Kurimoto A., DeWeck A.L., Dahinden C.A. Interleukin-3 dependent mediator release in basophils triggered by C5a. J. Exp. Med. 1989; 170: 467–479
   PubMed Web of Science ®Google Scholar
• Valent P., Besemer J., Muhm M., Majdic O., Lechner K., Bettelheim P. Interleukin-3 activates human blood basophils via high affinity binding sites. Proc. Natl. Acad. Sci. (USA) 1989; 86: 5542–5546
   PubMed Web of Science ®Google Scholar
• Kitamura T., Sato N., Arai K., Miyajima A. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 1991; 66: 1165–1173
   PubMed Web of Science ®Google Scholar
• Lopez A.F., Eglington J.M., Lyons A.B., Tapley P.M., To L.B., Park L.S., Clark S.C., Vadas M.A. Human interleukin-3 inhibits the binding of granulocyte macrophage colony stimulating factor and interleukin-5 to basophils and strongly enhances their functional properties. J. Cell Physiol. 1990; 145: 69–74
   PubMed Web of Science ®Google Scholar
• Agis H., Willheim M., Kundi M., Füreder W., Bankl H.C., Butterfield J.H., Sperr W.R., Kishi K., Lechner K., Valent P. Comparative phenotypic analysis of human mast cells, blood monocytes and blood basophils: Dissection of three distinct immunology myeloid cell lineages. 1996, in press
   Google Scholar
• Metcalf D., Nicola N.A. Tissue localization and fate in mice of injected multipotential colony stimulating-factor. Proc. Natl. Acad. Sci. (USA) 1986; 85: 3160–3164
   Web of Science ®Google Scholar
• Park L.S., Waldron P.E., Friend D., Sassenfeld H.M., Price V., Andersen D., Cosman D., Andrews R.G., Bernstein I.D., Urdal D.L. Interleukin-3, GM-CSF and G-CSF receptor expression on cell lines and primary leukemic cells: receptor heterogeneity and relationship to growth factor responsiveness. Blood 1989; 74: 56–65
   PubMed Web of Science ®Google Scholar
• Valent P., Besemer J., Sillaber Ch., Maurer D., Butterfield J.H., Kishi K., Lechner K., Bettelheim P. Failure to detect interleukin-3 binding sites on human mast cells. J. Immunol. 1990; 145: 3432–3438
   PubMed Web of Science ®Google Scholar
• Valent P., Spanblöchl E., Sperr W., Sillaber C., Agis H., Strobl H., Zsebo K.M., Geissler K., Bettelheim P., Lechner K. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor (SCF)/kit ligand (KL) in long term culture. Blood 1992; 80: 2237–2245
   PubMed Web of Science ®Google Scholar
• Mitsui H., Furitsu T., Dvorak A.M., Irani A. M. A., Schwartz L.B., Inagaki N., Takei M., Ishizaka K., Zsebo K.M., Gillis S., Ishizaka T. Development of human mast cells from umbilical cord blood cells by recombinant human and murine stem cell factor, c-kit ligand. Proc. Natl. Acad. Sci. (USA) 1993; 90: 735–740
   PubMed Web of Science ®Google Scholar
• Irani A.M., Nilsson G., Miettinen U., Craig S.S., Ashman L.K., Ishizaka T., Zsebo K.M., Schwartz L.B. Recombinant human stem cell factor stimulates differentiation of human mast cells from dispersed fetal liver cells. Blood 1992; 80: 3009–3016
   PubMed Web of Science ®Google Scholar
• Bischoff S.C., Dahinden C.A. c-kit Ligand: a unique potentiator of mediator release from human lung mast cells. J. Exp. Med. 1992; 175: 237–244
   PubMed Web of Science ®Google Scholar
• Columbo M., Horowitz E.M., Botana L.M., McGlashan D.W., Bochner B.S., Gillis S., Zsebo K.M., Galli S.J., Lichtenstein L.M. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. J. Immunol 1992; 149: 599–608
   PubMed Web of Science ®Google Scholar
• Sperr W.R., Czerwenka K., Mundigler G., Miiller M.R., Semper H., Klappacher G., Glogar H.D., Lechner K., Valent P. Specific activation of human mast cells by the ligand for c-kit: comparison between lung-, uterus and heart mast cells. Int. Arch. Allergy Appl. Immunol. 1993; 102: 170–175
   Google Scholar
• Mayrhofer G., Gadd S.J., Spargo L. D. J., Ashman L.K. Specificity of a mouse monoclonal antibody raised against acute myeloid leukemia cells for mast cells in human mucosal and connective tissues. Immunol. Cell. Bioi 1987; 65: 241–250
   PubMed Web of Science ®Google Scholar
• Sillaber C., Strobl H., Bevec D., Ashman L.K., Butterfield J.H., Lechner K., Maurer D., Bettelheim P., Valent P. IL-4 regulates c-kit proto-oncogene product expression in human mast and myeloid progenitor cells. J. Immunol. 1991; 147: 4224–228
   PubMed Web of Science ®Google Scholar
• Ashman L.K., Cambareri A.C., To L.B., Levinski R.J., Juttner C.A. Expression of c-kit antigen (c-kit proto-oncogen product) by normal human bone marrow cells. Blood 1991; 78: 30–37
   PubMed Web of Science ®Google Scholar
• Siitonen T., Savolainen E.R., Koistinen P. Expression of the c-kit proto-oncogene in myeloproliferative disorders and myelodysplastic syndromes. Leukemia 1994; 8: 631–637
   PubMed Web of Science ®Google Scholar
• Broudy V.C., Smith F.O., Lin N., Zsebo K.M., Egrie J., Bernstein I.D. Blasts from patients with acute myeloge-nous leukemia express functional receptors for stem cell factor. Blood 1992; 80: 60–67
   PubMed Web of Science ®Google Scholar
• Kitamura Y., Go S., Hatanaka S. Decrease of mast cells in W/W” mice and their increase by bone marrow transplantation. Blood 1978; 52: 447–452
   PubMed Web of Science ®Google Scholar
• Kitamura Y., Go S. Decreased production of mast cells in Sl/S1 mice. Blood 1979; 53: 492–497
   PubMed Web of Science ®Google Scholar
• Kitamura Y., Nakayama H., Fujita J. Mechanisms of mast cell deficiency in mutant mice of W/Wv and Sl/Sld genotype. Mast Cell and Basophil Differentiation and Function in Health and Disease, S.J. Galli, K.F. Austen. Raven Press Ltd, New York 1989; 12–15
   Google Scholar
• Furitsu T., Tsujimura T., Tono T., Ikeda H., Kitayama H., Koshimizu U., Sugahara H., Butterfield J.H., Ashman L.K., Kanayama Y., Matsuzawa Y., Kitamura Y., Kanakura Y. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of the c-kit product. J. Clin. Invest. 1993; 92: 1736–1744
   PubMed Web of Science ®Google Scholar
• De Castro C.M., Vandenbark G.R., Gautier M., Kaufman R.E. PCR-SSCP analysis of the c-kit gene in patients with hematologic disorders. Blood 1992; 80: 412a, (abst)
   PubMedGoogle Scholar
• Crosier P.S., Ricciardi S.T., Hall L.R., Vitas M.R., Clark C., Crosier K.E. Expression of isoforms of the human receptor tyorsine kinase c-kit in leukemic cell lines and acute myeloid leukemia. Blood 1993; 82: 1151–1158
   PubMed Web of Science ®Google Scholar
• Nagata H., Worobec A., Oh C., Suzuki Y., Metcalfe D.D. Identification of a point mutation of the proto-oncogene c-kit in patients with mastocytosis. J. All. Clin. Immunol. 1995; 95: 176, (abst)
   Web of Science ®Google Scholar
• Valent P., Bevec D., Maurer D., Besemer J., Butterfield J.H., Lechner K., Majdic O., Bettelheim P. Interleukin-4 promotes expression of mast cell ICAM-1 antigen. Proc. Natl. Acad. Sci. (USA) 1991; 88: 3339–3344
   PubMed Web of Science ®Google Scholar
• Schwartz L.B., Lewis R.A., Seldin D., Austen K.F. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells. J. Immunol. 1981; 126: 1290–1294
   PubMed Web of Science ®Google Scholar
• Yurt R.W., Leid R.W., Austen K.F., Silbert J.E. Native heparin from rat peritoneal mast cells. J. Biol. Chem. 1977; 252: 518–521
   PubMed Web of Science ®Google Scholar
• Benyon R.C., Bissonnette E.Y., Befus A.D. Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J. Immunol 1991; 147: 2253–2258
   PubMed Web of Science ®Google Scholar
• Miiller R., Heusser C.H., Rihs S., Brunner T., Bullock G.R., Dahinden C.A. Immunolocalization of intracellular interleukin-4 in normal human peripheral blood basophils. Eur. J. Immunol 1994; 24: 2935–2941
   PubMed Web of Science ®Google Scholar
• Castells M.C., Irani A. M. A., Schwartz L.B. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J. Immunol 1987; 138: 2184–2189
   PubMed Web of Science ®Google Scholar
• Dvorak A.M., Schleimer R.P., Lichtenstein L.M. Human mast cells synthesize new granules during recovery from degran-ulation. In vitro studies with mast cells purified from human lungs. Blood 1988; 71: 76–85
   PubMed Web of Science ®Google Scholar
• Irani A.A., Schechter N.M., Craig S.S., DeBlois G., Schwartz L.B. Two human mast cell subsets with distinct neutral protease composition. Proc. Natl. Acad. Sci. (USA) 1986; 83: 4464–4468
   PubMed Web of Science ®Google Scholar
• Lawrence I.D., Warner J.A., Cohan V.L., Hubbard W.C., Kagey-Sobotka A., Lichtenstein L.M. Purification and characterization of human skin mast cells. J. Immunol. 1987; 139: 3062–3069
   PubMed Web of Science ®Google Scholar
• Benyon R.C., Lowman M.A., Church M.K. Human skin mast cells: Their dispersion, purification, and secretory characterization. J. Immunol 1987; 138: 861–867
   PubMed Web of Science ®Google Scholar
• Fureder W., Agis H., Willheim M., Bankl H.C., Maier U., Kishi K., Muller M.R., Czerwenka K., Radaszkiewicz T., Butterfield J.H., Klappacher G., Sperr W.R., Oppermann M., Lechner K., Valent P. Differential expression of complement receptors on human basophils and mast cells: Evidence for mast cell heterogeneity and C5aR/CD88 expression on skin mast cells. J. Immunol 1995, in press
   PubMedGoogle Scholar
• Butterfield J.H., Weiler D., Dewald G., Gleich G.J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk. Res. 1988; 12: 345–355
   PubMed Web of Science ®Google Scholar
• Kishi K. A new leukemic cell line with Philadelphia chromosome characterized as basophil precursor. Leuk. Res. 1985; 9: 381–387
   PubMed Web of Science ®Google Scholar
• Nakazawa M., Mitjavila M.T., Debili N., Casadevall N., Mayeux P., Rouyer-Fessard P., Dubart A., Romeo P.H., Beuzard Y., Kishi K., Breton-Gorius J., Vainchenker W. KU-812: a pluripotent human cell line with spontaneous erythroid terminal differentiation. Blood 1989; 73: 2003–2013
   PubMed Web of Science ®Google Scholar
• Valent P., Besemer J., Kaltenbrunner R., Kuhn B., Kishi K., Bettelheim P. Interleukin-3 promotes basophilic differentiation of KU-812 cells via high affinity binding sites. J. Immunol. 1990; 145: 1885–1889
   PubMed Web of Science ®Google Scholar
• Denburg J.A., Wilson W. E. C., Goodacre R., Bienenstock J. Chronic myeloid leukemia: evidence for basophilic differentiation and histamine synthesis from cultured peripheral blood cells. Br. J. HaematoL 1980; 45: 13–21
   PubMed Web of Science ®Google Scholar
• Parkin J.L., McKenna R.W., Brunning R.D. Philadelphia chromosome positive blastic leukemia: ultrastruc-tural and ultracytochemical evidence of basophil and mast cell differentiation. Br. J. HaematoL 1982; 52: 563–677
   PubMed Web of Science ®Google Scholar
• Parmley R., Spicer S., Komiyama D., Dow L., Austin R. Ultrastructural cytochemistry of basophils in chronic my e-locytic leukemia. Mol. Pathol 1979; 30: 41–54
   Google Scholar
• Bosma T.J., Kennedy M.A., Bodger M., Hollings P.E., Fitzgerald P.H. Basophils exhibit rearrangement of the her gene in Philadelphia chromosome-positive chronic myeloid leukemia. Leukemia 1988; 2: 141–143
   PubMed Web of Science ®Google Scholar
• Denburg J.A., Browman G., Ali M., Benger A., Brain M., McBride J., Meyer R., Neame P., Nicholson W., Pai M., Powers P., Wilson W. E. C., Walker I. Prognostic implications of basophilic differentiation in chronic myeloid leukemia. Am. J. Hematol. 1988; 27: 110–114
   PubMed Web of Science ®Google Scholar
• Kantarjian H.M., Smith T.L., O'Brian S., Beran M., Pierce S., Talpaz M. Prolonged survival in chronic myeloid leukemia after cytogenetic response to interferon-a therapy. Ann. Internal. Meet. 1995; 122: 254–261
   PubMed Web of Science ®Google Scholar
• Nissenblatt M.J. Basophilic transformation of chronic myelogenous leukemia. South Med. J. 1980; 73: 1316–1319
   PubMed Web of Science ®Google Scholar
• Bettelheim P., Valent P. Radioimmunometrische Histaminbestimmung bei myeloproliferativen Syndromen. Wien Klin Wschr 1989; 101: 706–710
   PubMedGoogle Scholar
• Lett-Brown M.A., Jejuna H.S. Basophil function in patients with chronic myelogenous leukemia. Br. J. HaematoL 1985; 61: 621–626
   PubMed Web of Science ®Google Scholar
• Rosenthal S., Schwartz J.H., Canellos G.P. Basophilic chronic granulocytic leukemia with hyperhistami-naemia. Br. J. HaematoL 1977; 36: 367–372
   PubMed Web of Science ®Google Scholar
• Youman J.D., Taddeini L., Cooper T. Histamine excess symptoms in basophilic chronic granulocytic leukemia. Arch. Int. Med. 1973; 131: 560–562
   PubMed Web of Science ®Google Scholar
• Stain C., Stockinger H., Scharf M., Jager U., Gossinger H., Lechner K., Bettelheim P. Human blood basophils display a unique phenotype including activation linked membrane structures. Blood 1987; 70: 1872–1879
   PubMed Web of Science ®Google Scholar
• Valent P., Spanblochl E., Bankl H.C., Sperr W.R., Marosi C., Pirc-Danoewinata H., Virgolini I., Eichler H.G., Agis H., Sillaber C., Bettelheim P., Lechner K. Kit Ligand Mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemia blast crisis. Blond 1994; 84: 4322–1332
   PubMed Web of Science ®Google Scholar
• Rothenberg M.E., Caulfield J.P., Austen K.F., Hein A., Edmiston K., Newburger P.E., Stevens R.L. Biochemical and morphological characterization of basophilic leukocytes from two patients with myelogenous leukemia. J. Immunol. 1987; 138: 2616–2625
   PubMed Web of Science ®Google Scholar
• Pearson M.G., Vardiman J.W., LeBeau M.M., Rowley J.D., Schwarz S., Kerman S.L., Cohen M.M., Fleischman E.W., Prigonina E.L. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. Am. J. Hematol. 1985; 18: 393–403
   PubMed Web of Science ®Google Scholar
• Bodger M.P., Morris C.M., Kennedy M.A., Bowen J.A., Hilton J.M., Fitzgerald P.H. Basophils (Bsp-1+) derive from the leukemic clone in human myeloid leukemias involving the chromosome breakpoint 9 q34. Blood 1989; 73: 777–781
   PubMed Web of Science ®Google Scholar
• Horny H.P., Ruck M., Wehrmann M., Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myelo-proliferative disorders. Br. J. Haematol. 1990; 76: 186–193
   PubMed Web of Science ®Google Scholar
• Travis W.D., Li C.Y., Yam L.T., Bergstralh E.J., Swee R.G. Significance of systemic mast cell disease with associated hematologic disorders. Cancer 1988; 62: 965–972
   PubMed Web of Science ®Google Scholar
• Webb T.A., Li C.Y., Yam L.T. Systemic mast cell disease: a clinical and hematopathologic study of 26 cases. Cancer 1982; 49: 927–938
   PubMed Web of Science ®Google Scholar
• Horny H.P., Schaumberg-Lever G., Bolz S., Geerts M.I., Kaiserling E. Bone marrow findings in systemic mastocytosis. Human Pathology 1985; 16: 808–814
   PubMed Web of Science ®Google Scholar
• Lewis J.P., Welborn J.L., Meyers F.J., Levy N.B., Roschak T. Mast cell disease followed by leukemia with clonal evolution. Leuk. Res. 1987; 11: 769–773
   PubMed Web of Science ®Google Scholar
• Kimura A., Tanaka R., Taketomi Y., Dohi H., Fujimura K., Kamada N., Kuramoto A., Kajihara H., Aoki Y., Yamamoto S. A case of mastocytoma with leukemic manifestation of its immature form in the terminal stage. Rinsho Ketsueki 1979; 20: 1137–1146
   PubMedGoogle Scholar
• Metcalfe D.D. Classification and diagnosis of mastocytosis: current status. J. Invest. Dermatol. 1991; 96: 2S–4S
   Web of Science ®Google Scholar
• Travis W.D., Li C.Y., Hogaland H.C., Travis L.B., Banks P.M. Mast cell leukemia: Report of a case and review of the literature. Mayo. Clin. Proc 1986; 61: 957–966
   PubMed Web of Science ®Google Scholar
• Coser P., Quaglino D., De Pasquale A., Colombetti V., Prinoth O. Cytobiological and clinical aspects of tissue mast cell leukemia. Brit. J. Haematol 1980; 45: 5–12
   PubMed Web of Science ®Google Scholar
• Dalton R., Chan L., Batten E., Eridani S. Mast cell leukemia: evidence for bone marrow origin of the pathologic clone. Br. J. Hematol. 1986; 64: 397–406
   PubMed Web of Science ®Google Scholar
• Agis H., Bankl H.C., Sillaber C., Baghestanian M., Kiener H., Graninger W., Sperr W.R., Lechner K., Valent P. Biochemical and phenotypic characterization of cells in patients with malignant mastocytosis. Concordant absence of skin mast cell markers and lack of skin infiltrates, submitted
   Google Scholar
• Baghestanian M., Bankl H.C., Sillaber C., Beil W.J., Radaszkiewicz T., Fureder W., Preiser J., Veselly M., Schernthaner G., Lechner K., Valent P. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia
   PubMed Web of Science ®Google Scholar
• Kluin-Nelemans H.C., Jansen J.H., Breukelman H., Wolthers B.G., Kluin P.M., Kroon H.M., Willemze R. Response to interferon alpha-2b in a patient with systemic mastocytosis. N. Engl. J. Med 1992; 326: 619–623
   PubMed Web of Science ®Google Scholar
• Irani A.A., Garriga M.M., Metcalfe D.D., Schwartz L.B. Mast cells in cutaneous mastocytosis: accumulation of the MCTC type. Clin. Exp. Allergy 1990; 20: 53–58
   PubMed Web of Science ®Google Scholar
• Lawrence J.B., Friedman B.S., Travis W.D., Metcalfe D.D., Gralnick H.R. Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis. Am. J. Med. 1991; 91: 612–624
   PubMed Web of Science ®Google Scholar
• Willheim M., Agis H., Sperr W.R., Koller M., Bankl H.C., Kiener H., Fritsch G., Fureder W., Spittler A., Graninger W., Scheiner O., Gadner H., Lechner K., Boltz-Nitulescu G., Valent P. Purification of human basophils and mast cells to homogeneity by cell sorting with mAbs to CDw 17 and and CD 117/c-kit. J. Immunol. Methods 1995; 182: 115–129
   PubMed Web of Science ®Google Scholar